A different study of the U251 glioma cell line, however, suggested differently: after CCL2 knockdown, glioma cells exhibited significantly decreased proliferation and migration, and significantly increased apoptotic activity, as compared to control cells (56). The gene discussed is CCL2; the disease is glioma.